AzTrials
AzTrials

Endometriosis, RectumNCT04296760

Rectal Water-contrast Transvaginal Ultrasonography Versus Sonovaginography for the Diagnosis of Posterior Deep Pelvic Endometriosis

An observational study of Endometriosis, Rectum and Endometriosis of Vagina, run by Fabio Barra at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

As the surgical treatment of posterior deep endometriosis may be challenging for surgeons and carry significant risks for patients, preoperative assessment of the location, characteristics and presence of nodules of posterior deep endometriosis is important in order to inform the patient about the various treatment… Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Rectal water-contrast transvaginal ultrasonography and Sonovaginography
How many people
250 participants
Where
1 siteItaly
Study dates
1 Jan 2018to 1 Nov 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Adult, Older adult

Study population: Patients with suspicion of posterior deep infiltrating endometriosis, referring to our academic department for diagnostic purposes

Who may be able to join

  • clinical presentation suggestive of the presence of posterior deep infiltrating endometriosis

Who cannot join

  • previous diagnosis of posterior deep infiltrating endometriosis by radiologic imaging (i.e. magnetic resonance, computed tomography)
  • previous surgical diagnosis of posterior deep infiltrating endometriosis

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Ospedale Policlinico San Martino

    Genoa, 1632

Other trials in Italy

About this study

As the surgical treatment of posterior deep endometriosis may be challenging for surgeons and carry significant risks for patients, preoperative assessment of the location, characteristics and presence of nodules of posterior deep endometriosis is important in order to inform the patient about the various treatment possibilities and to allow adequate counseling regarding treatment strategy. The aim of this study is to investigate the accuracy of rectal water-contrast transvaginal ultrasonography (RWC-TVS), and sonovaginography (SVG) in patients with clinical suspicion of posterior deep endometriosis (DIE).

Being tested
Rectal water-contrast transvaginal ultrasonography, Sonovaginography
Keywords
rectosigmoid endometriosis; posterior pelvic deep endometriosis; vaginal endometriosis; rectovaginal endometriosis
Medical subject headings
Endometriosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rectal water-contrast transvaginal ultrasonographyDiagnostic test

    Transvaginal ultrasound scan combined with the introduction of saline solution into the rectum

  • SonovaginographyDiagnostic test

    Transvaginal ultrasound scan combined with the introduction of saline solution into the vagina

Study groups in NCT04296760
Study groupRoleWhat they receive
Women with suspicious of deep posterior pelvic endometriosisNot described
Receives: Diagnostic Test: Rectal water-contrast transvaginal ultrasonography; Diagnostic Test: Sonovaginography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy in diagnosing the presence of the following sites of posterior deep endometriosis: rectovaginal septum, rectosigmoid, uterosacral ligaments, and vagina

    Measured: At maximum 6 months before undergoing laparoscopic surgical approach

Secondary outcomes (4)
  1. Accuracy in estimating the deep of infiltration in the intestinal muscolari propria of nodules of rectosigmoid endometriosis

    Measured: At maximum 6 months before undergoing laparoscopic surgical approach

  2. Accuracy in estimating the distance between rectosigmoid endometriosis nodules and the anal verge

    Measured: At maximum 6 months before undergoing laparoscopic surgical approach

  3. Accuracy in diagnosing the presence of multifocal rectosigmoid endometriosis

    Measured: At maximum 6 months before undergoing laparoscopic surgical approach

  4. Accuracy in estimating the largest diameter of endometriosis nodules in the following sites of posterior deep endometriosis: rectovaginal septum, rectosigmoid, uterosacral ligaments, and vagina

    Measured: At maximum 6 months before undergoing laparoscopic surgical approach

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2020
  2. Study start1 Jan 2018
  3. Primary completion1 Nov 2020
  4. Study completion1 Nov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04296760
Sponsor's protocol ID
ENHANCED-ETV-ENDO
Status last verified
Nov 2020
First submitted
3 Mar 2020
Last updated
17 Nov 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Leone Roberti Maggiore U, Biscaldi E, Vellone VG, Venturini PL, Ferrero S. Magnetic resonance enema vs rectal water-contrast transvaginal sonography in diagnosis of rectosigmoid endometriosis. Ultrasound Obstet Gynecol. 2017 Apr;49(4):524-532. doi: 10.1002/uog.15934.

    PubMed 27060846
  • Ferrero S, Biscaldi E, Vellone VG, Venturini PL, Leone Roberti Maggiore U. Computed tomographic colonography vs rectal water- contrast transvaginal sonography in diagnosis of rectosigmoid endometriosis: a pilot study. Ultrasound Obstet Gynecol. 2017 Apr;49(4):515-523. doi: 10.1002/uog.15905.

    PubMed 26935873

Questions about this trial

What is this clinical trial studying?

An observational study of Endometriosis, Rectum and Endometriosis of Vagina, run by Fabio Barra at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy in diagnosing the presence of the following sites of posterior deep endometriosis: rectovaginal septum, rectosigmoid, uterosacral ligaments, and vagina (time frame: At maximum 6 months before undergoing laparoscopic surgical approach). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04296760, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in